End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.5 TWD | -3.09% | -6.45% | -12.11% |
Mar. 19 | Sinew Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sinew Pharma Inc.(TPEX:6634) added to S&P Global BMI Index | CI |
Sales 2022 | 0.33 10.67 | Sales 2023 | - | Capitalization | 4.8B 156B |
---|---|---|---|---|---|
Net income 2022 | -140M -4.55B | Net income 2023 | -171M -5.56B | EV / Sales 2022 | 18,117,189,024 x |
Net cash position 2022 | 1.38B 44.99B | Net cash position 2023 | 1.27B 41.18B | EV / Sales 2023 | - |
P/E ratio 2022 |
-51.9
x | P/E ratio 2023 |
-27.9
x | Employees | 52 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.59% |
1 day | -3.09% | ||
1 week | -6.45% | ||
Current month | -12.76% | ||
1 month | -8.60% | ||
3 months | -10.79% | ||
6 months | -12.11% | ||
Current year | -12.11% |
Managers | Title | Age | Since |
---|---|---|---|
Kai Min Zhu
CEO | Chief Executive Officer | - | 14-06-17 |
Tzu Wen Chen
DFI | Director of Finance/CFO | - | - |
Cheng Hui Hsiung
CTO | Chief Tech/Sci/R&D Officer | - | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chih Chuan Chen
BRD | Director/Board Member | - | - |
Li Chun Han
BRD | Director/Board Member | 66 | 19-06-26 |
Tu Mu Kuo
BRD | Director/Board Member | - | 19-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 59.5 | -3.09% | 210,277 |
24-04-17 | 61.4 | -2.38% | 49,693 |
24-04-16 | 62.9 | -0.16% | 53,690 |
24-04-15 | 63 | -0.79% | 24,558 |
24-04-12 | 63.5 | -0.16% | 31,770 |
End-of-day quote Taipei Exchange, April 17, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-12.11% | 130M | |
-1.82% | 41.35B | |
+42.10% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- 6634 Stock